accelerated radiation therapy

RADIATION2 trials

Sponsors

NCIC Clinical Trials Group, University of Miami

Conditions

Head and Neck CancerLocally Advanced Rectal Cancer

Phase 1

SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer

RecruitingNCT05412082

University of MiamiLocally Advanced Rectal Cancer

Start: 2022-10-05End: 2028-10-31Target: 25Updated: 2026-02-06

Phase 3

Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer

CompletedNCT00820248

NCIC Clinical Trials GroupHead and Neck Cancer

Start: 2008-12-30End: 2017-02-17Updated: 2023-08-22

Related Papers

Resource utilization in patients with head and neck cancer: Analysis of CCTG HN6 (NCT00820248).

Journal of Clinical Oncology2017-05-20

Quality of life and swallowing with standard chemoradiotherapy versus accelerated radiotherapy and panitumumab in locoregionally advanced carcinoma of the head and neck: A phase III randomised trial from the Canadian Cancer Trials Group (HN.6).

2016-12-2915 citations

Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma

JAMA Oncology2016-12-0870 citations

Phase III randomized trial of standard fractionation radiotherapy (SFX) with concurrent cisplatin (CIS) versus accelerated fractionation radiotherapy (AFX) with panitumumab (PMab) in patients (pts) with locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): NCIC Clinical Trials Group HN.6 trial.

Journal of Clinical Oncology2015-05-2022 citations

Quality of life (QOL) in a phase III randomized trial of standard fractionation radiotherapy (SFX) with concurrent cisplatin (CIS) versus accelerated fractionation radiotherapy (AFX) with panitumumab (PMab) in patients (pts) with locoregionally advanced squamous cell carcinoma of the head and neck (LA-SCCHN): NCIC Clinical Trials Group HN.6 (NCT00820248).

Journal of Clinical Oncology2015-05-203 citations

Cancer patients’ acceptability of incorporating an epidemiology questionnaire within a clinical trial: A patient preference study and subanalysis of the NCIC clinical trials group HN.6 clinical trial.

Journal of Clinical Oncology2014-05-201 citations